These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 11281339

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
    Leoncini G, Martinoli C, Viazzi F, Ravera M, Parodi D, Ratto E, Vettoretti S, Tomolillo C, Derchi LE, Deferrari G, Pontremoli R.
    Nephron; 2002 Feb; 90(2):169-73. PubMed ID: 11818701
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH.
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [Abstract] [Full Text] [Related]

  • 4. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V, Devereux RB.
    Minerva Cardioangiol; 2002 Jun 25; 50(3):169-74. PubMed ID: 12107398
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
    Díez J, Laviades C.
    J Hypertens Suppl; 1994 Jul 25; 12(4):S31-6. PubMed ID: 7965272
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov 25; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 12. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B, Nalbantgil S, Yilmaz H, Zoghi M, Ozerkan F, Nalbantgil I, Onder R.
    Saudi Med J; 2004 Dec 25; 25(12):1975-8. PubMed ID: 15711679
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine.
    Attwood S, Bird R, Burch K, Casadei B, Coats A, Conway J, Dawes M, Ebbs D, Farmer A, Robinson J.
    J Hypertens; 1994 Sep 25; 12(9):1053-60. PubMed ID: 7852749
    [Abstract] [Full Text] [Related]

  • 15. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group.
    Diabet Med; 2004 Nov 25; 21(11):1192-9. PubMed ID: 15498085
    [Abstract] [Full Text] [Related]

  • 16. Lisinopril in essential hypertension: a six month comparative study with nifedipine.
    Richardson PJ, Meany B, Breckenridge AM, Grimmer SF, Johnston GD, Kondowe G.
    J Hum Hypertens; 1987 Dec 25; 1(3):175-9. PubMed ID: 2852252
    [Abstract] [Full Text] [Related]

  • 17. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
    Wu SC, Liu CP, Chiang HT, Lin SL.
    Heart Vessels; 2004 Jan 25; 19(1):13-8. PubMed ID: 14685749
    [Abstract] [Full Text] [Related]

  • 18. Lisinopril versus slow release nifedipine in patients with essential hypertension: a multicentre study.
    Predel HG, Kramer HJ.
    J Hum Hypertens; 1994 Oct 25; 8(10):777-80. PubMed ID: 7837215
    [Abstract] [Full Text] [Related]

  • 19. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H.
    Am J Hypertens; 2006 Dec 25; 19(12):1233-40. PubMed ID: 17161768
    [Abstract] [Full Text] [Related]

  • 20. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 25; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.